Global Veterinary Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Veterinary Oncology Market is presumed to reach the market size of nearly USD 1024.82 BN by 2030 from USD 309.72 BN in 2022 with a CAGR of 14.22% under the study period 2023 - 2030.

Veterinary oncology is basically the diagnosis and treatment of pets suffering from cancer. Dogs and cats are more prone to develop diseases like skin cancer and bone cancer. It uses the Hurt Hunger Hydration Hygiene Happiness Mobility Scale to discuss and identify their quality of life with pet owners before making a euthanasia decision for the treatment of these diseases. Factors that lead to cancer in pets include constant exposure of animal skin to the sun and external environment, viruses, and carcinogens such as smoke, pesticides, UV light and radioactive waste.

MARKET DYNAMICS:

The increase in the prevalence of cancer diseases such as lymphoma, skin cancer, mast cell cancer etc. is leading to high demand for the veterinary oncology market. Rising pet adoption and a growing focus on pet health are surging the demand for this market. An increase in the number of veterinary clinical studies for evaluating the safety and efficiency of oncology drugs is fostering the demand for this market. In addition, an increase in funding from private & government organizations for animal care centres and a rise in R&D activities for oncology treatment in pets are boosting the demand for this market. Moreover, the presence of key manufacturing companies in veterinary oncology treatment and rise in animal healthcare expenditure is also propelling the market growth during the study.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary oncology. The growth and trends of veterinary oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the veterinary oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others

By Animal Type

Canine
Feline

By Cancer Type

Lymphoma
Mast Cell Cancer
Mammary And Squamous Cell Cancer
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Oncology market include PetCure Oncology, Zoetis Inc., Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218350

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . VETERINARY ONCOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapy
- 3.7.2 Market Attractiveness Analysis By Animal Type
- 3.7.3 Market Attractiveness Analysis By Cancer Type
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY

6.1 Overview by Therapy
6.2 Historical and Forecast Data
6.3 Analysis by Therapy
6.4 Surgery Historic and Forecast Sales by Regions
6.5 Radiotherapy Historic and Forecast Sales by Regions
6.6 Chemotherapy Historic and Forecast Sales by Regions
6.7 Immunotherapy Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

7.1 Overview by Animal Type
7.2 Historical and Forecast Data
7.3 Analysis by Animal Type
7.4 Canine Historic and Forecast Sales by Regions
7.5 Feline Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY CANCER TYPE

8.1 Overview by Cancer Type
8.2 Historical and Forecast Data
8.3 Analysis by Cancer Type
8.4 Lymphoma Historic and Forecast Sales by Regions
8.5 Mast Cell Cancer Historic and Forecast Sales by Regions
8.6 Mammary And Squamous Cell Cancer Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

10.1. Veterinary Oncology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. PetCure Oncology
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Zoetis Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Karyopharm Therapeutics Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Varian Medical Systems
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Accuray Incorporated
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Boehringer Ingelheim GmbH
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Elanco
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. One Health
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Regeneus Ltd
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies